Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* breast cancer patients~* who are treated with chemotherapy or hormonal therapy~* who experience no menstruation after the previous therapy~* who complain of vaginal dryness~Exclusion Criteria:~* other cancer patients~* other severe disease~* poor compliance

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Clino-san 2ml vaginal application 3 times per week for 12 weeks
- 2 (Type: PLACEBO_COMPARATOR): placebo 2ml vaginal application 3 times per week for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).